Oncology — continuous care programmesSymptom monitoring
between cycles.
The weeks between treatment cycles are where toxicity shows up and where patients are most alone with it. Structured monitoring turns that gap into something the team can see.
What applies here, and why.
Which programme suits a given panel is a clinical and documentation decision. This is the shape we see most often — treat it as a starting point for a conversation, not a prescription.
- Physiologic measures relevant to the regimen and the patient
- Patient-reported symptoms and toxicity between cycles
- Comorbidities that treatment destabilises
The value is in catching the deterioration that would otherwise arrive as an emergency-department visit. Thresholds are set by the treating oncologist for the regimen and the patient.
How it runs
Oncology panels vary enormously by practice, regimen, and payer. Treat any programme shape as a starting point to be adjusted with your team.
Thresholds set by the physician, not by a default.
Escalation logic, alert bands, and care-plan rules are specified by a physician who has run them — which is why what reaches the chart is clinically meaningful rather than raw telemetry.
A threshold that fires on every patient is noise, and noise gets ignored. The escalation rules are written per patient, by the clinician who knows what a change actually means for them.
Codes that commonly apply.
What each one requires, and what it pays, lives in the CPT reference — one source, so nothing drifts.
Run this in your oncology practice. We will tell you what it takes.
Tell us your panel and the system you run. We will be straight about which programme fits and what the documentation actually requires.